Cecily Kulsick, DNP is the Nurse Practitioner in the Beth Israel Deaconess Medical Center (BIDMC) Liver Tumor Multidisciplinary Clinic. Her unique role is shared across Hepatology, Medical Oncology, Interventional Radiology, Radiation Oncology, and Hepatobiliary Surgery. She sees a broad spectrum of patients throughout the disease continuum from pre-diagnosis, post-procedure, survivorship, and those with cirrhosis management needs throughout their disease journey. She also staffs the BIDMC Splanchnic Vein Thrombosis Multidisciplinary Clinic.

Dr. Jaime Chu is a Professor of Pediatrics and Medical Director of Pediatric Liver Transplantation at the Mount Sinai Kravis Children's Hospital and Mount Sinai's Recanati/Miller Transplantation Institute. Dr. Chu is a physician-scientist in pediatric hepatology. In addition to caring for children with liver disease and liver transplants, she leads a translational research group that focuses on how metabolism pathways regulate liver development and disease, including MASLD.

Dr. Bril is currently an Assistant Professor and Associate Scientist in the Division of Endocrinology, Diabetes and Metabolism at the University of Alabama at Birmingham (UAB). He completed medical school and 4 years of internal medicine residency at Instituto Universitario CEMIC in Buenos Aires, Argentina. Before redoing clinical training in the US, he completed a research fellowship in Endocrinology, Diabetes and Metabolism at University of Florida. He then completed internal medicine residency and endocrinology fellowship at University of Alabama at Birmingham.

Dr. Sanyal is a leading global authority in liver diseases and ranked in the top 0.1% of biomedical scientists worldwide and currently serves as the Chair of the Division of Gastroenterology, Hepatology and Nutrition and Director of the Stravitz-Sanyal Institute for Liver Diseases and Metabolic Health at Virginia Commonwealth University.

Dr. Ryutaro Hirose was appointed Chief of the Division of Transplant Surgery at the University of Washington and Co - Director of the UW Medicine Transplant Institute, starting his position on November 1, 2023. Dr. Hirose is a senior and well-known transplant surgeon who had previously worked at UCSF. He has extensive experience in UNOS, within the American Society of Transplant Surgeons (ASTS) , and he currently serves as the Surgical Director of the Scientific Registry of Transplant Recipients (SRTR). As a leader in transplantation, Dr.

Dr. Girgrah is the Chief Wellness Officer at Ochsner Health. He leads the efforts of the Office of Professional Well-Being (OPW) at Ochsner Health which is charged with improving the professional fulfillment of their employed physicians and healthcare workforce focusing on enhanced practice efficiency and personal and team resilience and building an organizational culture that promotes provider well-being. Dr. Girgrah received both his medical degree and Ph.D. from the University of Toronto.

Kristin Hatcher is a dedicated advocate for drug development and education, known for her impactful work in both fields. With a background in pharmaceutical sciences and education, Kristin has dedicated her career to bridging the gap between research and practical application, ensuring that advancements in drug development translate into real-world benefits.

Through her advocacy in drug development, Kristin actively collaborates with patients, pharmaceutical companies, researchers, and health organizations to promote innovative treatments and therapies.

Dr. Laura Bonebrake is an OB/Gyn physician currently practicing in St. Louis, Missouri. She is a strong advocate for the connections between women's health and liver health and brings her unique perspective as an OB/Gyn to this advocacy.

Her main research focus is on Intrahepatic Cholestasis of Pregnancy and she also has a personal connection with this disease in her pregnancies. Current focus involves the connection of ICP with lifelong liver health and other cholestatic liver disorders.